These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9572902)

  • 1. An investigation of FB interactions with poly(ethylene glycol) 6000, poly(ethylene glycol) 4000, and poly-epsilon-caprolactone by thermoanalytical and spectroscopic methods and modeling.
    Lacoulonche F; Chauvet A; Masse J; Egea MA; Garcia ML
    J Pharm Sci; 1998 May; 87(5):543-51. PubMed ID: 9572902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior.
    Vippagunta SR; Wang Z; Hornung S; Krill SL
    J Pharm Sci; 2007 Feb; 96(2):294-304. PubMed ID: 17051588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties.
    Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y
    Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-aggregation of cationically modified poly(ε-caprolactone)
    Charoongchit P; Suksiriworapong J; Sripha K; Mao S; Sapin-Minet A; Maincent P; Junyaprasert VB
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():444-455. PubMed ID: 28024608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the thermo- and pH-responsive assembly of triblock copolymers based on poly(ethylene glycol) and functionalized poly(ε-caprolactone).
    Safaei Nikouei N; Lavasanifar A
    Acta Biomater; 2011 Oct; 7(10):3708-18. PubMed ID: 21672641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
    Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microwave-assisted synthesis of poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) tri-block co-polymers and use as matrices for sustained delivery of ibuprofen taken as model drug.
    Yu Z; Liu L
    J Biomater Sci Polym Ed; 2005; 16(8):957-71. PubMed ID: 16128231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer.
    Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A
    Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of a unique crystal morphology for the poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymer.
    He C; Sun J; Zhao T; Hong Z; Zhuang X; Chen X; Jing X
    Biomacromolecules; 2006 Jan; 7(1):252-8. PubMed ID: 16398522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable and thermoreversible hydrogels of poly(ethylene glycol)-poly(epsilon-caprolactone-co-glycolide)-poly(ethylene glycol) aqueous solutions.
    Jiang Z; Hao J; You Y; Liu Y; Wang Z; Deng X
    J Biomed Mater Res A; 2008 Oct; 87(1):45-51. PubMed ID: 18080306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of polymer composition on rheological and degradation properties of temperature-responsive gelling systems composed of acyl-capped PCLA-PEG-PCLA.
    Petit A; Müller B; Meijboom R; Bruin P; van de Manakker F; Versluijs-Helder M; de Leede LG; Doornbos A; Landin M; Hennink WE; Vermonden T
    Biomacromolecules; 2013 Sep; 14(9):3172-82. PubMed ID: 23875877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological control of poly(ethylene glycol)-block-poly(epsilon-caprolactone) copolymer aggregates in aqueous solution.
    Fairley N; Hoang B; Allen C
    Biomacromolecules; 2008 Sep; 9(9):2283-91. PubMed ID: 18702541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability.
    Ramos Yacasi GR; Calpena Campmany AC; Egea Gras MA; Espina García M; García López ML
    Drug Dev Ind Pharm; 2017 Apr; 43(4):637-651. PubMed ID: 28044462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (ε-caprolactone) copolymer micelles for the delivery of curcumin.
    Song Z; Zhu W; Song J; Wei P; Yang F; Liu N; Feng R
    Drug Deliv; 2015 Jan; 22(1):58-68. PubMed ID: 24725028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
    Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
    Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored protein release from biodegradable poly(ε-caprolactone-PEG)-b-poly(ε-caprolactone) multiblock-copolymer implants.
    Stanković M; Tomar J; Hiemstra C; Steendam R; Frijlink HW; Hinrichs WL
    Eur J Pharm Biopharm; 2014 Jul; 87(2):329-37. PubMed ID: 24602675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalized (poly(ɛ-caprolactone))₂-poly(ethylene glycol) nanoparticles with grafting nicotinic acid as drug carriers.
    Suksiriworapong J; Sripha K; Kreuter J; Junyaprasert VB
    Int J Pharm; 2012 Feb; 423(2):562-70. PubMed ID: 22155410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.